Twelve dialysis patients received oral pulse therapy with 1-alpha-hydr
oxyvitamin D-3 in a dose of 0.1 mu g/kg body weight twice weekly and d
aily calcium carbonate (1.5-3.5 g) for a period of 8-12 months. This t
reatment was very effective in suppressing secondary hyperparathyroidi
sm without causing hypercalcaemia and/or hyperphosphataemia.